Psychiatry and Neurology, Neurology · Rochester, NY
NPI
1245242981
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
20 Hagen Dr, Suite 300
Rochester, NY, 14625
Phone (585) 586-7550
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
15,231 services
Medicare patients, 2024
144
Average age 72
Drug cost, 2024
$871K
3,026 prescriptions
Company payments, 2025
$459
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan V Evans was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,860 times for 25 patients. In total Ryan V Evans billed 15,231 services in 21 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,860 | 25 | $4.97 | $74K |
| 99215 Office E&M - Established | Office | 71 | 46 | $113.95 | $8,090 |
| 99214 Office E&M - Established | Office | 70 | 54 | $80.31 | $5,622 |
| 64615 Musculoskeletal | Office | 53 | 17 | $107.17 | $5,680 |
| 95885 Electrical Nerve Conductivity | Office | 24 | 23 | $44.15 | $1,059 |
| 99205 Office E&M - New | Office | 19 | 19 | $155.69 | $2,958 |
| 95910 Electrical Nerve Conductivity | Office | 19 | 18 | $118.23 | $2,246 |
| 99204 Office E&M - New | Office | 14 | 14 | $103.93 | $1,455 |
By year: 2022 $111K for 16,102 services; 2023 $119K for 16,553 services; 2024 $108K for 15,231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ryan V Evans prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 325 prescriptions and refills. In total Ryan V Evans wrote 3,026 Medicare prescriptions that cost $871K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 325 | 853 | 108 | $21K |
| Gabapentin Generic | 231 | 412 | 78 | $4,139 |
| Memantine Hcl Generic | 98 | 156 | 27 | $1,918 |
| Topiramate Generic | 93 | 167 | 26 | $1,798 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 91 | 232 | 30 | $5,474 |
| Donepezil Hcl Generic | 87 | 195 | 36 | $762 |
| Aimovig Autoinjector Erenumab-Aooe | 83 | 115 | 17 | $81K |
| Rizatriptan Rizatriptan Benzoate | 81 | 81 | 15 | $898 |
| Levetiracetam Generic | 80 | 172 | 18 | $3,158 |
| Baclofen Generic | 78 | 96 | 13 | $1,103 |
| Clonazepam Generic | 78 | 112 | 24 | $983 |
| Lamotrigine Generic | 77 | 134 | 19 | $2,274 |
| Duloxetine Hcl Generic | 74 | 140 | 18 | $1,764 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 64 | 116 | 15 | $1,609 |
| Primidone Generic | 61 | 126 | 14 | $1,778 |
Brand drugs: 307 claims; generic drugs: 2,698 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan V Evans $459 ($459 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $314.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.